New treatment for COVID-19 is made from plants
Researchers at Arizona State University describe an innovative therapy using transient expression in tobacco plants to produce a monoclonal antibody against SARS-CoV-2. This class 4 mAb provides key advantages over existing treatments, including mutation resistance and universal protection against emerging variants.
SourceArizona State University·JournalPlant Biotechnology Journal·TypeExperimental study·DateFeb 25, 2023